National Institute of Allergy and Infectious Diseases(NIAID)
Scope
Date
~
-
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...
Apr 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Remsima SC in Denmark
South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...
Apr 19, 2024 (Gmt+09:00)
-
Electric vehicles
EVs in S.Korea exceed 500,000
The cumulative number of electric vehicles (EVs) registered in South Korea exceeded 500,000 last year.The number of EV chargers supplied domesticall...
Apr 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung begins new drug development for rare diseases
Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...
Mar 24, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
In South Korea, Instagram thrives while Facebook declines
In South Korea, one of the world’s most wired countries, people can’t live without social networking services for everyday communication...
Mar 19, 2024 (Gmt+09:00)
-
Bio & Pharma
Reversing age possible in a decade: Harvard Prof. David Sinclair
Humans will be able to control biological age and reverse their age in 10 years with advancements in medical science and live up to around 120, abou...
Mar 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion'a autoimmune disease drug Zymfentra makes US debut
South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...
Mar 18, 2024 (Gmt+09:00)
-
Automobiles
Tata Daewoo resumes truck exports to Algeria
South Korea's Tata Daewoo Commercial Vehicle Company announced on Tuesday that it resumed truck exports to Algeria under the Daewoo brand. Tata...
Mar 12, 2024 (Gmt+09:00)
-
Korean stock market
NPS to invest up to $8.2 bn in undervalued Korean stocks
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, is expected to invest up to 11 trillion won ($8.2 ...
Mar 01, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion ships initial supply of Zymfentra to US
South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...
Feb 29, 2024 (Gmt+09:00)
-
Korean SMEs
S.Korean boiler firms expand exports
Despite a global economic slowdown, South Korea's overseas exports of boilers and water heaters increased 4.9% year over year by $478.3 million in 2...
Feb 27, 2024 (Gmt+09:00)
-
Artificial intelligence
Kakao Brain releases medical GenAI tech for free
Kakao Brain, an artificial intelligence (AI) R&D subsidiary of South Korea's Kakao Corp., announced on Tuesday that it has uploaded the Labeler ...
Feb 20, 2024 (Gmt+09:00)
-
Economy
South Korea’s corporate tax-to-GDP ratio hits record high
South Korean companies paid more corporate taxes than their rivals in developed countries in 2022, losing competitiveness, with the nation’s c...
Feb 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to deliver three treatments to Peru
South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...
Feb 15, 2024 (Gmt+09:00)
-
Business & Politics
South Korea establishes diplomatic ties with Cuba
South Korea has established diplomatic relations with Cuba, a close ally of North Korea, Seoul said on Wednesday. Cuba had long been the only count...
Feb 15, 2024 (Gmt+09:00)
-
Aerospace & Defense
Hanwha, Saudi gov't to cooperate in defense industry
Hanwha Aerospace Co. and Hanwha Systems Co. announced on Tuesday that they signed a three-party memorandum of understanding (MOU) for defense cooper...
Feb 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima SC, Yuflyma to Norway
South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...
Feb 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Kakao launches AI-based blood sugar management solution
South Korea’s Kakao Healthcare Corp. has introduced an artificial intelligence-based blood sugar management solution targeting the global digi...
Feb 01, 2024 (Gmt+09:00)
-
Food & Beverage
Orion, VNUA to team up for potato production
South Korea’s confectionery and snack maker Orion Corp. announced on Friday that it signed a strategic partnership agreement with the Institut...
Jan 26, 2024 (Gmt+09:00)
-
Batteries
Hyundai Motor in deal to secure lithium hydroxide from China’s Chengxin
South Korea’s top automaker Hyundai Motor Group has agreed to secure lithium hydroxide, a key raw material for electric vehicle batteries, fro...
Jan 11, 2024 (Gmt+09:00)
-
Regulations
South Korea Ban Takes Dog Meat Off the Menu
SEOUL—Dog meat will no longer be allowed in South Korea, capping a decadeslong campaign against a controversial practice that many locals have...
Jan 10, 2024 (Gmt+09:00)
-
Automobiles
IONIQ 5 named Car of the Year 2023 in Singapore
Hyundai Motor Co.'s electric sport utility vehicle (SUV) IONIQ 5 has been selected as the Car of the Year 2023 in Singapore by the nation’s la...
Jan 02, 2024 (Gmt+09:00)
-
Economy
S.Korea to allow hiring of foreign workers in hotels, resorts
The South Korean government said on Friday that it would grant the hiring of foreign workers in hotels and resorts from next year.The hotel and reso...
Dec 29, 2023 (Gmt+09:00)
-
Business & Politics
South Korea eyes new Arab boom via free trade deal with GCC nations
South Korea has struck a free trade agreement with the Gulf Cooperation Council (GCC), a group of six Arab nations, paving the way for Seoul to stre...
Dec 28, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Ocean carrier HMM's share price gains put KDB in hot seat
On Nov. 20, HMM Co., South Korea’s No. 1 ocean carrier, issued new 200 million shares after its two largest shareholders -- Korea Development ...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
ToolGen gets FDA approval for TGT-001 as ODD
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
Dec 18, 2023 (Gmt+09:00)
-
IPOs
LS Materials’ share price quadruples on Kosdaq debut
The share price of LS Materials Co., a South Korean energy storage device maker, quadrupled on its Kosdaq market debut Wednesday given its rosy earn...
Dec 12, 2023 (Gmt+09:00)
-
North Korea
Kim Jong Un urges women to be good comrades — and give birth
SEOUL—Kim Jong Un has a new mission for North Korean women: Have more babies.Kim acknowledged the impoverished nation’s plunging bi...
Dec 07, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Ocean to develop submarine technology to evade detection
South Korea's Hanwha Ocean Co. has consecutively secured contracts for naval technology-related vessel research projects. The company recently annou...
Nov 29, 2023 (Gmt+09:00)
-
Bio & Pharma
SK C&C to promote AI healthcare for brain diseases
South Korea's SK C&C announced on Thursday that it signed a strategic business agreement with Neurophet, a cloud-based AI platform for brain ima...
Nov 23, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand